Literature DB >> 2463126

Combined immunodeficiency with abnormal expression of MHC class II genes.

C Griscelli1, B Lisowska-Grospierre, F Le Deist, A Durandy, A Marcadet, A Fischer, C de Preval, B Mach.   

Abstract

The MHC class II CID represents an example of immunodeficiency in which the defect in expression of membrane glycoproteins leads to abnormal cell to cell interactions and thus to abnormal immune responses. It represents an interesting model which confirms the importance of MHC molecules in all immune responses to foreign antigens. It also underlines the complexity of regulatory mechanism which control the expression of MHC class II genes. To elucidate these mechanisms, it is essential to identify and characterize the genes involved in control of MHC class II expression.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2463126     DOI: 10.1016/0090-1229(89)90121-9

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  6 in total

Review 1.  Impaired regulation of HLA-DR expression in human immunodeficiency virus-infected monocytes.

Authors:  Ling Shao; Kirk Sperber
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

Review 2.  The expression of HLA-DO (H2-O) in B lymphocytes.

Authors:  Xinjian Chen; Peter E Jensen
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

3.  The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population.

Authors:  Hamid Naamane; Ouafaa El Maataoui; Fatima Ailal; Abdelhamid Barakat; Siham Bennani; Jilali Najib; Mohammed Hassar; Rachid Saile; Ahmed Aziz Bousfiha
Journal:  Eur J Pediatr       Date:  2010-04-23       Impact factor: 3.183

4.  Autoimmune haemolytic anaemia in a child with MHC class II deficiency.

Authors:  G Horneff; R C Seitz; V Stephan; V Wahn
Journal:  Arch Dis Child       Date:  1994-10       Impact factor: 3.791

5.  Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX.

Authors:  B Durand; M Kobr; W Reith; B Mach
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

6.  Clinical, immunological and genetic features in eleven Algerian patients with major histocompatibility complex class II expression deficiency.

Authors:  Réda Djidjik; Nesrine Messaoudani; Azzedine Tahiat; Yanis Meddour; Samia Chaib; Aziz Atek; Mohammed Elmokhtar Khiari; Nafissa Keltoum Benhalla; Leila Smati; Abdelatif Bensenouci; Mourad Baghriche; Mohammed Ghaffor
Journal:  Allergy Asthma Clin Immunol       Date:  2012-08-03       Impact factor: 3.406

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.